RevoluGen Demonstrates Superior Automated Magnetic Bead-Based HMW-DNA Extraction with its Fire Monkey Chemistry Under Collaboration with LGC Biosearch Technologies

HADFIELD, United Kingdom, Jan. 30, 2024 (GLOBE NEWSWIRE) — UK genomics company, RevoluGen Ltd., has demonstrated a new protocol for automated bead-based high molecular weight HMW-DNA extraction with its proprietary Fire Monkey chemistry.

Under a collaboration with LGC Biosearch TechnologiesTM, RevoluGen has coupled its Fire Monkey chemistry with LGC magnetic beads and LGC oKtopureTM liquid handling robot to produce ready to use HMW-DNA.

The proof-of-concept study demonstrated that the production of HMW-DNA suitable for both short- and long-read sequencing can now be automated for high-sample number applications.

The mammalian cell HMW-DNA was extracted by the automated Fire Monkey magnetic bead protocol on the LGC oKtopure robot. Due to the unique features of the Fire Monkey chemistry the extracts contain very little of the smaller fragments (under 10kb) that are extracted with other HMW-DNA nucleic acid isolation and purification (NAIP) kits and require time and material consuming size selection post-extraction.

The HMW DNA was then sequenced on a single Oxford Nanopore MinION flow cell without size-selection post-extraction and produced N50 results of 44.89kb and raw throughput of 21.03Gb using the LSK114 kit.

Dr Georgios Patsos, inventor of the Fire Monkey technology and CSO at RevoluGen said, “DNA extraction using magnetic bead-based protocols are now the most widely used. Our collaboration with LGC has demonstrated that our spin column-based technology can be transferred to a bead-based protocol with easy automation. Fire Monkey HMW-DNA extraction can lower the overall cost of multiplexed sequencing and accelerate the uptake of sequencing in many high-volume dependent applications. We look forward to commercialising this new innovation.”

Darren Cook, VP Business Development and Product Management, LGC Biosearch Technologies said, “We are delighted to have worked with Georgios and the RevoluGen team to demonstrate the ability to extract HMW-DNA using our beads and automated sample handling instrument. Their success underscores our commitment to pioneering innovation and our ethos of co-creation with our customers, so that together we can help advance genomics-based science across the globe.”

In addition to the benefits brought about through bead-based automation, Fire Monkey technology unites sample preparation for both short-read and long-read DNA sequencing by providing flexibility to revisit the same original sample for more detailed long-read sequencing after a first run with lower cost short-read sequencing. This can reduce sample handling and storage significantly by only needing to do one extraction rather than two for producing hybrid assemblies cost effectively.

About RevoluGen – www.revolugen.co.uk.

RevoluGen is a UK-based privately held scientific research and development company commercialising molecular tools with a specific focus on rapidly extracting long and pure DNA fragments from cells.

RevoluGen’s Nucleic Acid Isolation and Purification (NAIP) products have broad application across all of both short- and long-read DNA sequencing technologies, including their use in particular for population genomics, epidemiological mutation screening and antibiotic microbial resistance gene monitoring.

Fire Monkey significantly improves sequencing results by extracting long-fragment DNA with a simultaneous size selection function built into the protocol that minimises the small-fragment DNA contamination.

Follow us on X/Twitter and LinkedIn

Watch our film https://vimeo.com/465291714 and animation https://lnkd.in/dHy3E3s

For more information or to arrange media interviews please contact:

RevoluGen media contact

Sue Charles, Director and Head Corporate Communications

Tel +44 (0)7968 726585, sue@revolugen.com

About LGC
LGC is a leading, global life science tools company providing mission-critical components and solutions into high-growth application areas across the human healthcare and applied market segments. LGC’s tools play a key role in customer workflows from discovery applications through to commercial manufacture and enable its customers to bring new diagnostics and therapies to market, optimise food production and optimise food production.

About LGC Biosearch Technologies

LGC Biosearch Technologies is the comprehensive genomics portfolio from LGC, providing products and services for genomic analysis that support mission critical applications for global customers in agrigenomics and human healthcare. We offer tools and technologies to accelerate sample preparation, amplification, cloning, expression, next generation sequencing (NGS), oligonucleotide synthesis, and nucleic acid chemistry. We collaborate with our customers by applying our expertise in NGS, genotyping, PCR, and qPCR to enable them to achieve more than they thought possible.

LGC media contacts

Magda Bartoszewicz

Tel +44 (0)7522 141 822, magda.barto@lgcgroup.com

Jennifer Wells

Tel +44 (0)7917 684 183, jennifer.wells@lgcgroup.com

Staff

Recent Posts

Daily Fit Notes Rolls Out Affordable Fitness Solutions for the Modern Lifestyle

Daily Fit Notes, founded by Justin Brey in New York, launches a text-based subscription fitness…

2 days ago

WillowWood Rebrand by DD.NYC Wins Gold Anthem Award for Product and Innovation in 2024 Rebrand

MT. STERLING, Ohio, Dec. 20, 2024 /PRNewswire/ -- WillowWood, a global leader in prosthetic solutions,…

2 days ago

Quantum Biopharma Announces Closing of Second Tranche

TORONTO, ON / ACCESSWIRE / December 20, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma"…

2 days ago

Glow Lifetech Announces Completion of Final Payment under Swiss Pharma Share Exchange Agreement and Debt Settlement

Toronto, Ontario--(Newsfile Corp. - December 20, 2024) - Glow Lifetech Corp. (CSE: GLOW) (OTC Pink:…

2 days ago